title: Balancing the benefits and risks of empirical antibiotics for sinusitis: a teachable moment.
authors.affiliation: Department of Emergency Medicine, Denver Health Medical Center, Denver, Colorado2Department of Emergency Medicine, University of Colorado Hospital, Aurora.
authors.forename: Avery
authors.initials: A
authors.lastname: MacKenzie
mesh_terms: D000208:Acute Disease; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D000077525:Cefdinir; D002511:Cephalosporins / Q000009:adverse effects*; D004761:Enterocolitis, Pseudomembranous / Q000209:etiology*; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D008297:Male; D012220:Rhinitis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D018570:Risk Assessment; D012852:Sinusitis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D002511:Cephalosporins; D000069285:Infliximab; D000077525:Cefdinir